Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

MEK1 Inhibitor Selumetinib Sensitizes Precursor B-Cell Acute Lymphoblastic Leukemia Cells (B-ALL) to Dexamethasone through Modulation of mTOR Activity and Stimulation of Autophagy

Anna Polak, MSc, Przemyslaw Kiliszek, MSc, Tomasz Sewastianik, MSc, Maciej Szydlowski, PhD, Ewa Jablonska, PhD, Emilia Bialopiotrowicz, PhD, Patryk Gorniak, PhD, Sergiusz Markowicz, PhD, Eliza Nowak, MSc, Monika A. Grygorowicz, MSc, Dominika Nowis, MDPhD, Jakub Golab, MD PhD, Sebastian Giebel, MD PhD, Ewa Lech-Maranda, MD PhD, Krzysztof Warzocha, MD PhD, Przemyslaw Juszczynski, MD PhD

Blood (2015) 126 (23): 4917.

https://doi.org/10.1182/blood.V126.23.4917.4917

Published: 2015

Journal Articles

SK053, an Inhibitor of Enzymes Involved in Allosteric Disulfide Bonds Formation, Targets Expression of Histone Genes and Induces Differentiation of Human AML Cell

Justyna Chlebowska, M.Sc., Pawel Gaj, PhD, Piotr Stawinski, M.Sc., Michal Lazniewski, M.Sc., Malgorzata Firczuk, PhD, Karolina Furs, Radoslaw Sadowski, Szymon Klossowski, M.Sc., Ryszard Ostaszewski, PhD, Jakub Golab, MD PhD, Krzysztof Giannopoulos, MD PhD, Rafal Ploski, MD, PhD, Dominika Nowis, MD, PhD

Blood (2014) 124 (21): 3503.

https://doi.org/10.1182/blood.V124.21.3503.3503

Published: 2014

Journal Articles

HDAC Inhibitors As Potential New Agents Improving the Efficacy of Monoclonal Antibodies

Malgorzata Bobrowicz, MSc, Michal Dwojak, DMD, Agata Malenda, MD PhD, Kamil Bojarczuk, MSc, Marta Siernicka, MSc, Beata Pyrzynska, PhD, Ewa Lech-Maranda, MD PhD, Tomasz Stoklosa, MD PhD, Magdalena Winiarska, PhD, Jakub Golab, MD PhD

Blood (2014) 124 (21): 3641.

https://doi.org/10.1182/blood.V124.21.3641.3641

Published: 2014

Journal Articles

Peroxiredoxins-1 and 2 Affect Proliferation and Survival of Lymphoma Cells

Malgorzata Firczuk, PhD, Anna Trzeciecka, MDStudent, Malgorzata Bajor, PhD, Angelika Muchowicz, PhD, Radoslaw Zagozdzon, MD PhD, Joanna Barankiewicz, MD, Antoni Domagala, MDStudent, Szymon Klossowski, M.Sc., Agata Malinowska, M.Sc., Justyna Chlebowska, M.Sc., Ryszard Ostaszewski, PhD, Jakub Golab, MD PhD, Dominika Nowis, MD, PhD

Blood (2014) 124 (21): 1693.

https://doi.org/10.1182/blood.V124.21.1693.1693

Published: 2014

Journal Articles

Src Family Tyrosine Kinases Are Involved in the Transcriptional Regulation of CD20 Levels

Magdalena Winiarska, PhD, Jacek Bil, MD, PhD, Kamil Bojarczuk, BSc, Dominika Nowis, MD, PhD, Malgorzata Wanczyk, MSc, Michal Dwojak, Grzegorz Basak, MD, PhD, Tomasz Stoklosa, MD, PhD, Jakub Golab, MD, PhD

Blood (2011) 118 (21): 1661.

https://doi.org/10.1182/blood.V118.21.1661.1661

Published: 2011

Journal Articles

Prenyl Transferases Are Involved in the Regulation of CD20 Levels and Influence Anti-CD20 Monoclonal Antibody-Mediated Activation of Complement-Dependent Cytotoxicity,

Dominika Nowis, MD, PhD, Magdalena Winiarska, PhD, Jacek Bil, MD, PhD, Angelika Muchowicz, MSc, Malgorzata Wanczyk, MSc, Eliza Glodkowska-Mrowka, MD, Kamil Bojarczuk, BSc, Malgorzata Firczuk, PhD, Ewa Wilczek, PhD, Malgorzata Wachowska, MSc, Justyna Chlebowska, MSc, Michal Dwojak, Marta Miaczynska, PhD, Tomasz Stoklosa, MD, PhD, Jakub Golab, MD, PhD

Blood (2011) 118 (21): 3722.

https://doi.org/10.1182/blood.V118.21.3722.3722

Published: 2011

Journal Articles

Sorafenib Affects Membrane Complement Inhibitors and Improves Antitumor Activity of Rituximab,

Jakub Golab, MD, PhD, Jacek Bil, MD, PhD, Kamil Bojarczuk, BSc, Dominika Nowis, MD, PhD, Marcin Okroj, Ph.D., Grzegorz Basak, MD, PhD, Tomasz Stoklosa, MD, PhD, Magdalena Winiarska, PhD

Blood (2011) 118 (21): 3723.

https://doi.org/10.1182/blood.V118.21.3723.3723

Published: 2011

NARROW

MEK1 Inhibitor Selumetinib Sensitizes Precursor B-Cell Acute Lymphoblastic Leukemia Cells (B-ALL) to Dexamethasone through Modulation of mTOR Activity and Stimulation of Autophagy

SK053, an Inhibitor of Enzymes Involved in Allosteric Disulfide Bonds Formation, Targets Expression of Histone Genes and Induces Differentiation of Human AML Cell

HDAC Inhibitors As Potential New Agents Improving the Efficacy of Monoclonal Antibodies

Peroxiredoxins-1 and 2 Affect Proliferation and Survival of Lymphoma Cells

Src Family Tyrosine Kinases Are Involved in the Transcriptional Regulation of CD20 Levels

Prenyl Transferases Are Involved in the Regulation of CD20 Levels and Influence Anti-CD20 Monoclonal Antibody-Mediated Activation of Complement-Dependent Cytotoxicity,

Sorafenib Affects Membrane Complement Inhibitors and Improves Antitumor Activity of Rituximab,

Email alerts

ASH Publications

American Society of Hematology

MEK1 Inhibitor Selumetinib Sensitizes Precursor B-Cell Acute Lymphoblastic Leukemia Cells (B-ALL) to Dexamethasone through Modulation of mTOR Activity and Stimulation of Autophagy

SK053, an Inhibitor of Enzymes Involved in Allosteric Disulfide Bonds Formation, Targets Expression of Histone Genes and Induces Differentiation of Human AML Cell

HDAC Inhibitors As Potential New Agents Improving the Efficacy of Monoclonal Antibodies

Peroxiredoxins-1 and 2 Affect Proliferation and Survival of Lymphoma Cells

Src Family Tyrosine Kinases Are Involved in the Transcriptional Regulation of CD20 Levels

Prenyl Transferases Are Involved in the Regulation of CD20 Levels and Influence Anti-CD20 Monoclonal Antibody-Mediated Activation of Complement-Dependent Cytotoxicity,

Sorafenib Affects Membrane Complement Inhibitors and Improves Antitumor Activity of Rituximab,

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only